海外の治験の状況「1」での検索結果
2039件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Authorised
- Autoregulation af den glomerulære filtrations rate (GFR) under spironolacton behandling hos type 1 diabetikere. - Blodtryksbehandling med spironolacton og beskyttelse af nyrefunktionen.
- Hypertension in patients with type 1 diabetes
- Denmark
- 2006-05-11
Authorised
- Eficacia de rapamicina en prevención secundaria de tumores cutáneos en trasplantados renales. Estudio abierto, aleatorizado, comparando rapamicina con inhibidores de calcineurina. - Tumorapa-1
- Comparar el efecto de dos estrategias inmunosupresoras sobre la incidencia de nuevos carcinomas espinocelulares en pacientes con trasplante renal que hayan desarrollado un primer carcinoma espinocelular. To evaluate the impact of two imnosupressive regimens on the incidence of skin cancers among patients who has a first spinocellular skin cancer after renal transplantation MedDRA version: 9.1 Level: LLT Classification code 10038533 Term: Renal transplant
- Spain
- 2007-05-24
Authorised
- Tailored treatment of hepatitis C genotype 1 - TTG1
- Chronic infection with hepatitis C virus, genotype 1, with signs of liver inflammation.
- Sweden
- 2007-03-13
Authorised
- Estudio prospectivo para la evaluación de la seguridad y eficacia a largo plazo de CX401 en pacientes que han participado en el ensayo FATT-1
- Fistula perianal compleja MedDRA version: 9 Level: LLT Classification code 10002156 Term: Anal fistula
- Spain
- 2008-06-25
Authorised
- Study to Evaluate the Safety and Efficacy of CB-03-01 1% Cream Applied Twice-Daily for 12 Weeks in Subjects with Facial Acne Vulgaris
- facial acne vulgaris MedDRA version: 18.1 Level: LLT Classification code 10000519 Term: Acne vulgaris System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Romania, United States
- 2015-10-26
Authorised
- Study to Evaluate the Safety and Efficacy of CB-03-01 1% Cream Applied Twice-Daily for 12 Weeks in Subjects with Facial Acne Vulgaris
- facial acne vulgaris MedDRA version: 18.0 Level: LLT Classification code 10000519 Term: Acne vulgaris System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Bulgaria, Romania, United States
- 2015-10-07
Authorised
- A clinical study investigating the safety and tolerability of brexpiprazole in the Treatment of Subjects with Bipolar I Disorder
- Treatment of Manic Episodes Associated with Bipolar I Disorder MedDRA version: 20.0 Level: LLT Classification code 10068455 Term: Bipolar I disorder, hypomanic System Organ Class: 100000004873 ;Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]
- Bulgaria, Croatia, Poland, Romania, Serbia, Ukraine, United States
- 2018-01-12
Authorised
- "Activation microgliale dans la Narcolepsie de type 1: medical imaging study"
- To study in vivo microglial activation by PET [18F] DPA-714 in NT1 patients with recent evolution (appearance of the first symptoms - somnolence and cataplexy-less than 2 years ago) compared with controlled subjects (followed for another pathology of sleep without narcolepsy or hypersomnia) matched in age and sex.;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- France
- 2018-08-27
Authorised
- Effect of montelukast on levels of metalloproteinase-9 (MMP-9), MMP-12, tissue inhibitor metalloproteinase-1 (TIMP-1), procollagen peptide type 1 C-terminal (PICP) and TGF-beta1 on induced sputum of children suffering from intermittent asthma. - ND
- Intermittent asthma MedDRA version: 9.1 Level: LLT Classification code 10003553 Term: Asthma
- Italy
- 2008-12-30
Authorised
- A study of the effectiveness and safety of Octafibrin, a replacement for fibrinogen, in patients with inherited fibrinogen deficiency causing episodes of bleeding.
- Congenital fibrinogen deficiency. MedDRA version: 18.1 Level: LLT Classification code 10066357 Term: Congenital hypofibrinogenemia System Organ Class: 100000004850 MedDRA version: 18.1 Level: LLT Classification code 10066356 Term: Congenital hypofibrinogenaemia System Organ Class: 100000004850 ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Bulgaria, Egypt, India, Lebanon, Russian Federation, Saudi Arabia, Turkey, United Kingdom
- 2014-04-30